BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4629882)

  • 21. Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage.
    Numaguchi Y; Zoarski GH; Clouston JE; Zagardo MT; Simard JM; Aldrich EF; Sloan MA; Maurer PK; Okawara SH
    Neuroradiology; 1997 Oct; 39(10):751-9. PubMed ID: 9351116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiographic study of vasospasm following subarachnoid hemorrhage in monkeys.
    Peerless SJ; Fox AJ; Komatsu K; Hunter IG
    Stroke; 1982; 13(4):473-9. PubMed ID: 7101347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical grade, regional cerebral blood flow, and angiographical spasm in the monkey after subarachnoid hemorrhage.
    Petruk KC
    Trans Am Neurol Assoc; 1973; 98():142-4. PubMed ID: 4206368
    [No Abstract]   [Full Text] [Related]  

  • 24. Papaverine-sensitive vasospasm and arterial contractility and compliance after subarachnoid hemorrhage in dogs.
    Macdonald RL; Zhang J; Sima B; Johns L
    Neurosurgery; 1995 Nov; 37(5):962-7; discussion 967-8. PubMed ID: 8559346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraarterial papaverine for relief of catheter-induced intracranial vasospasm.
    Eckard DA; Purdy PD; Girson MS; Samson D; Kopitnik T; Batjer H
    AJR Am J Roentgenol; 1992 Apr; 158(4):883-4. PubMed ID: 1546611
    [No Abstract]   [Full Text] [Related]  

  • 26. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.
    Varsos VG; Liszczak TM; Han DH; Kistler JP; Vielma J; Black PM; Heros RC; Zervas NT
    J Neurosurg; 1983 Jan; 58(1):11-7. PubMed ID: 6847896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG-626).
    Alksne JF; Branson PJ
    Stroke; 1979; 10(6):638-44. PubMed ID: 118551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm.
    Lewis PJ; Weir BK; Nosko MG; Tanabe T; Grace MG
    Neurosurgery; 1988 Mar; 22(3):492-500. PubMed ID: 3362315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm.
    McAuliffe W; Townsend M; Eskridge JM; Newell DW; Grady MS; Winn HR
    J Neurosurg; 1995 Sep; 83(3):430-4. PubMed ID: 7666218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental cerebral vasospasm. Part 2: effects of vasoactive drugs and sympathectomy on early and late spasm.
    Nagai H; Noda S; Mabe H
    J Neurosurg; 1975 Apr; 42(4):420-8. PubMed ID: 1123659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical aggravation of vasospasm with papaverine infusion following aneurysmal subarachnoid hemorrhage. Case report.
    Clyde BL; Firlik AD; Kaufmann AM; Spearman MP; Yonas H
    J Neurosurg; 1996 Apr; 84(4):690-5. PubMed ID: 8613866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kanamaru K; Grace M; Baughman R
    Neurosurgery; 1990 Feb; 26(2):201-6. PubMed ID: 2106630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage.
    Elliott JP; Newell DW; Lam DJ; Eskridge JM; Douville CM; Le Roux PD; Lewis DH; Mayberg MR; Grady MS; Winn HR
    J Neurosurg; 1998 Feb; 88(2):277-84. PubMed ID: 9452236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ther reversal of experimental vasospasm by dibutyryl-3',5'-adenosine monophosphate.
    Peterson EW; Searle R; Mandy FF; Leblanc R
    J Neurosurg; 1973 Dec; 39(6):730-4. PubMed ID: 4357243
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe thrombocytopenia following intraarterial papaverine administration for treatment of vasospasm.
    Miller JA; Cross DT; Moran CJ; Dacey RG; McFarland JG; Diringer MN
    J Neurosurg; 1995 Sep; 83(3):435-7. PubMed ID: 7666219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of prostaglandin E 1 on experimental cerebral vasospasm.
    Pelofsky S; Jacobson ED; Fisher RG
    J Neurosurg; 1972 May; 36(5):634-9. PubMed ID: 4623728
    [No Abstract]   [Full Text] [Related]  

  • 37. Transient neurologic events associated with intraarterial papaverine infusion for subarachnoid hemorrhage-induced vasospasm.
    Mathis JM; DeNardo A; Jensen ME; Scott J; Dion JE
    AJNR Am J Neuroradiol; 1994 Oct; 15(9):1671-4. PubMed ID: 7847211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for symptomatic vasospasm after subarachnoid hemorrhage].
    Fujiwara N; Honjo Y; Ohkawa M; Takashima H; Tanabe M; Nagao S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jun; 57(7):412-7. PubMed ID: 9232990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-operative micro-angioplasty of refractory vasospasm secondary to subarachnoid hemorrhage.
    Dion JE; Duckwiler GR; ViƱuela F; Martin N; Bentson J
    Neuroradiology; 1990; 32(3):232-6. PubMed ID: 2145526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of cerebral vasospasm.
    Peterson EW; Mandy FF; Searle R; Leblanc R
    Lancet; 1973 Jun; 1(7818):1513. PubMed ID: 4123178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.